Insulet (PODD) Asset Writedowns and Impairment (2010 - 2026)
Insulet (PODD) posted Asset Writedowns and Impairment of $300000.0 for Q1 2026, up 200.0% on a QoQ basis from $100000.0 in Q3 2025, and down 93.62% year-over-year from $4.7 million in Q1 2025.
Insulet (PODD) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Insulet's Asset Writedowns and Impairment history runs 17 years deep, the most recent figure standing at $300000.0 for Q1 2026.
- Quarterly Asset Writedowns and Impairment fell 93.62% year-over-year to $300000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (up 71.88% YoY) and the FY2024 annual result came in at -$200000.0, down 108.7% from the prior year.
- Asset Writedowns and Impairment was $300000.0 for Q1 2026 at Insulet, up from $100000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $4.7 million in Q1 2025 and bottomed at -$900000.0 in Q4 2024.
- A 5-year average of $780000.0 and a median of $800000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment soared 450.0% — and 2024, when it tumbled 550.0%.
- Insulet's Asset Writedowns and Impairment stood at $1.1 million in 2022, then plunged by 81.82% to $200000.0 in 2023, then tumbled by 550.0% to -$900000.0 in 2024, then soared by 111.11% to $100000.0 in 2025, then jumped by 200.0% to $300000.0 in 2026.
- Business Quant data shows PODD's Asset Writedowns and Impairment at $300000.0 in Q1 2026, $100000.0 in Q3 2025, and $400000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Insulet | 11.52 Bn | 11.04 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 4.70 Mn |
| Mar 31, 2025 | 4.70 Mn |
| Dec 31, 2024 | -900,000.00 |
| Dec 31, 2024 | -900,000.00 |
| Jun 30, 2024 | -600,000.00 |
| Jun 30, 2024 | -600,000.00 |
| Mar 31, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 800,000.00 |